Clinical Trials Browser

Phase 1/2 × dinaciclib × Dermatologic × Clear all

NCT01026324 2017-04-04

Dinaciclib in Treating Patients With Stage III-IV Melanoma

Phase 1/2 Terminated

12 enrolled 9 charts

Melanoma